Creightons PLC | Annual Report 2024 | ||
Consolidated income statement | |||
Year ended | Year ended | ||
31 March | 31 March | ||
2024 | 2023 | ||
Note | £000 | £000 | |
Revenue | 4,5 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Distribution costs | ( | ( | |
Administrative expenses | ( | ( | |
Operating profit before exceptional items | |||
Exceptional items - Redundancy costs | 7 | ( | ( |
Exceptional items – Impairment | 8, 14 | ( | |
Operating profit | ( | ||
Exceptional items - Acquisition costs | 8 | ( | |
Finance costs | 9 | ( | ( |
Profit before tax | ( | ||
Taxation | 10 | ( | ( |
(Loss) / Profit for the year attributable to the equity shareholders | ( | ||
Consolidated statement of comprehensive income | Year ended | Year ended | |
31 March | 31 March | ||
2024 | 2023 | ||
£000 | £000 | ||
(Loss) / Profit for the year | ( | ||
Items that may be subsequently reclassified to profit and loss: | |||
Exchange differences on translating foreign operations | ( | ||
Other comprehensive income for the year | ( | ||
Total comprehensive income for the year attributable to the equity | ( | ||
shareholders | |||
Earnings per share | Year ended | Year ended | |
31 March | 31 March | ||
Note | 2024 | 2023 | |
Basic | 12 | ( | |
Diluted * | 12 | ( | |
* Share options are excluded from the earnings per share calculation for the year ended 31 March 2024 due to their anti-dilutive effect on the loss after tax attributable to equity holders. | |||
Adjusted Earnings per share – alternate performance measure | |||
The following calculation of the basic and diluted earnings per share excluding exceptional items has been calculated | |||
based on adding back the following deductions from (loss) / profit after tax: | Year ended | Year ended | |
31-Mar | 31-Mar | ||
Note | 2024 | 2023 | |
£000 | £000 | ||
(Loss) / Profit for the period from operations attributable to the equity | ( | ||
shareholders of the parent Company | |||
Exceptional items – Impairment | 8,13,14 | ||
Exceptional items – Deferred tax charge not previously recognised | 31 | ||
Exceptional items – Acquisition costs (disallowed for tax provision) | 8 | ||
Adjusted Earnings excluding exceptional items | 12 | ||
Adjusted Basic earnings per share – excluding exceptional items | 12 | ||
Adjusted Diluted earnings per share – excluding exceptional items | 12 |
Creightons PLC Annual Report 2024 68 Consolidated balance sheet | |||
31 March | 31 March | ||
2024 | 2023 | ||
Note | £000 | £000 | |
Non-current assets | |||
Goodwill | 13 | ||
Other intangible assets | 14 | ||
Property, plant and equipment | 15 | ||
Right-of-use assets | 16 | ||
Current assets | |||
Inventories | 18 | ||
Trade and other receivables | 19 | ||
Cash and cash equivalents | 20 | ||
Total assets | |||
Current liabilities | |||
Trade and other payables | 22 | ||
Corporation tax payable | 22 | ||
Lease liabilities | 23 | ||
Borrowings | 24 | ||
Net current assets | |||
Non-current liabilities | |||
Deferred tax liability | 31 | ||
Lease liabilities | 23 | ||
Borrowings | 24 | ||
Total liabilities | |||
Net assets | |||
Equity | |||
Share capital | 25 | ||
Share premium account | |||
Merger reserve | |||
Treasury shares | 8 | ( | ( |
Other reserves | ( | ( | |
Translation reserve | |||
Retained earnings | |||
Total equity attributable to the equity shareholders of the parent Company |
Share | Share | |||||||
capital | premium | Merger | Treasury | Other | Translation | Retained | Total | |
(note | account | reserve | Shares | reserves | reserve | earnings | equity | |
25) | ||||||||
£000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
At 1 April 2022 | ( | |||||||
Comprehensive income for the year | ||||||||
Profit for the year | ||||||||
Exchange differences | ||||||||
on translation of foreign operations | ( | ( | ||||||
Total | ||||||||
comprehensive income for the year | ( | |||||||
Contributions by and distributions to owners | ||||||||
Exercise of options | ||||||||
Purchase of own shares (Note 8) | ( | ( | ||||||
Share-based | ||||||||
payment charge | ||||||||
(note 26) | ||||||||
Deferred tax through Equity (note 31) | ( | ( | ||||||
Total contributions | ||||||||
by and distributions to owners | ( | ( | ( | |||||
At 31 March 2023 | ( | ( | ||||||
Comprehensive income for the year | ||||||||
Loss for the year | ( | ( | ||||||
Exchange differences | ||||||||
on translation of foreign operations | ||||||||
Total | ||||||||
comprehensive | ( | ( | ||||||
loss for the year | ||||||||
Contributions by and distributions to owners | ||||||||
Exercise of options | ||||||||
Share-based | ||||||||
payment charge | ||||||||
(note 26) | ||||||||
Deferred tax through Equity (note 31) | ( | ( | ||||||
Total contributions | ||||||||
by and distributions to owners | ||||||||
At 31 March 2024 | ( | ( |
Note | Year ended 31 | Year ended 31 | |
March | March | ||
2024 | 2023 | ||
£000 | £000 | ||
Profit from operations including redundancy costs | |||
Adjustments for: | |||
Depreciation on property, plant and equipment | 15 | ||
Depreciation on right of use assets | 16 | ||
Amortisation of intangible assets | 14 | ||
Loss/(Profit) on disposal of Right of Use assets | 6 | ||
Share based payment charge | 26 | ||
Decrease in inventories | 18 | ||
Decrease in trade and other receivables | 19 | ||
(Decrease) in trade and other payables | ( | ( | |
Cash generated from operations | |||
Taxation paid | ( | ( | |
Net cash generated from operating activities | |||
Investing activities | |||
Purchase of property, plant and equipment | 15 | ( | ( |
Purchase of intangible assets | 14 | ( | ( |
Acquisition of Brodie & Stone | 8 | ( | |
Acquisition of Emma Hardie | 8 | ( | |
Net cash used in investing activities | ( | ( | |
Financing activities | |||
Proceeds on issue of shares | 25 | ||
Cancellation of leases | 23 | ( | ( |
Principal paid on lease liabilities | 23 | ( | ( |
Utilisation of invoice financing facilities | 30 | ||
Repayment of invoice financing facilities | 30 | ( | |
Repayment of amounts borrowed | 30 | ( | ( |
Repayment on term loan | 30 | ( | ( |
Interest paid on term loan | 30 | ( | |
Repayment on mortgage loan facility | 30 | ( | ( |
Interest paid on mortgage loan facility | 30 | ( | |
Purchase of shares - Share buy back | 8 | ( | |
Net cash generated (used in) financing activities | ( | ( | |
Net increase in cash and cash equivalents | |||
Cash and cash equivalents at start of year | |||
Effect of foreign exchange rate changes | ( | ||
Cash and cash equivalents at end of year |